National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Edoxaban is indicated for the prevention of stroke/SE in adults with NVAF and for the treatment/secondary prevention of DVT and PE in adults.

Rapid Review

Commenced Completed Outcome
26/06/2015 10/07/2015 Full Pharmacoeconomic Evaluation Not Recommended